about
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosisImmunotherapeutic approaches for hepatocellular carcinomaNatural history of malignant bone disease in hepatocellular carcinoma: final results of a multicenter bone metastasis survey.Prolactin variations during risperidone therapy in a sample of drug-naive children and adolescents.Nonalcoholic steatohepatitis: recent advances from experimental models to clinical management.Ribavirin-induced anemia: mechanisms, risk factors and related targets for future research.Non-alcoholic fatty liver disease in the metabolic syndrome.Oxidative stress-induced risk factors associated with the metabolic syndrome: a unifying hypothesis.Hepatocellular carcinoma treatment over sorafenib: epigenetics, microRNAs and microenvironment. Is there a light at the end of the tunnel?Management of gallstones and its related complications.Risperidone and Cardiometabolic Risk in Children and Adolescents: Clinical and Instrumental Issues.Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience.The p66Shc protein controls redox signaling and oxidation-dependent DNA damage in human liver cells.Basal and bevacizumab-based therapy-induced changes of lactate dehydrogenases and fibrinogen levels and clinical outcome of previously untreated metastatic colorectal cancer patients: a multicentric retrospective analysis.Haemodynamic effects of propranolol, octreotide and their combination during fasting and post-prandial splanchnic hyperaemia in patients with cirrhosis.Glutathione peroxidase, thioredoxin, and membrane protein changes in erythrocytes predict ribavirin-induced anemia.Hepatotoxicity of polyunsaturated fatty acids in alcohol abuser.Mitochondrial glutathione content determines the rate of liver regeneration after partial hepatectomy in eu- and hypothyroid rats.Structural and oxidative modifications of erythrocyte ghosts in patients with primary biliary cirrhosis: relation with the disease stage and effect of bile acid treatment.Adaptation of subcellular glutathione detoxification system to stress conditions in choline-deficient diet induced rat fatty liver.Liver function as assessed by breath tests in patients with hepatocellular carcinoma.Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale.Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.Metabolic syndrome: differences between psychiatric and internal medicine patients.Changes of gallbladder and gastric dynamics in patients with acute hepatitis A.Gallbladder motor function in gallstone patients: sonographic and in vitro studies on the role of gallstones, smooth muscle function and gallbladder wall inflammation.Validation of a Simple Scoring System to Predict Sorafenib Effectiveness in Patients with Hepatocellular Carcinoma.Tolerability and safety profile of risperidone in a sample of children and adolescents.Red blood cells (RBC) deformability and aggregability: alterations in alcoholism.Effects of cholestyramine on gallbladder and gastric emptying in obese and lean subjects.T16189C mitochondrial DNA variant is associated with metabolic syndrome in Caucasian subjects.Assessment of ultrasound acoustic artifacts in patients with acute dyspnea: a multicenter studyProlonged consumption of moderate doses of alcohol and in vitro gastro-duodenal and ileal contractility in the ratEffect of glutathione administration on hepatic biliary and plasmatic glutathione levels in the ratChronic ethanol administration induces oxidative alterations and functional impairment of pancreatic mitochondria in the ratMutual changes of thioredoxin and nitrosothiols during biliary cirrhosis: results from humans and cholestatic ratsAdefovir dipivoxyl for the treatment of delta-related liver cirrhosisEthanol induces secretion of oxidized proteins by pancreatic acinar cellsLiver breath tests non-invasively predict higher stages of non-alcoholic steatohepatitisLong-term ursodeoxycholate improves circulating redox changes in primary biliary cirrhotic patients
P50
Q28943317-E92C2B2F-D644-4261-9EB7-131531D41C8EQ33779723-D79DA57A-1E01-464A-8C8D-0467E71125C3Q34109952-80C1340F-D1EF-415F-9B0B-EC7E387CE3B1Q35038921-837CE3DB-6963-448E-B281-1976FA8A0F51Q36039854-FEA58C6E-549C-4D0D-A1F0-AC7A9EF8520EQ36683930-FF25752F-2A5B-4B30-901E-E9CB384AA8E9Q36879419-5B4C3799-7245-4810-A2AB-743E03078FFBQ36940271-DB5864C2-CA7D-4CF6-96D4-9D07589E7D3AQ38554626-39A61BA7-E776-4170-8771-BDBE2F500A40Q38631199-88EE6F36-8F57-4100-B9DA-CB08C9716C23Q38879899-D7609362-7C34-40FF-83E8-9E64DA694594Q40411310-E21DED3B-3461-49B5-AEFB-C4A65789D19EQ41017508-1945B796-8247-438A-986D-050FB2F6B28FQ42468728-ABF4B293-C8AB-41C2-8653-7F091D278B44Q43541158-58E9AC57-585D-4FCD-88AF-C59050BFC65EQ43575122-F0D92097-D964-44E6-AFB0-E68FF67EC3A9Q44071074-DBEC0AAC-9522-4E6A-BE6B-16104F9CF0A1Q44583419-1D3E961E-6F0C-4C8C-B983-236119CA838BQ44597488-9248487C-830D-4959-9AA3-5FBD06CF3239Q44796361-66A805CD-D30F-4FFE-A16B-074C6EC3E9ADQ45961655-35D2E534-4172-4DB9-B5C5-3AF38E239665Q47686470-18658C3E-F187-43B7-B921-2FDCCA38EDA7Q47945856-8ABC1B2F-07F4-4C1A-B11E-A7C6DF5E0E6AQ48422028-CE144310-7E31-4648-9ECD-24809B0EF766Q49211853-9C2A7338-5575-4373-B2B7-3EEE78B84AD7Q50167402-225F87CD-5920-45D3-9179-B796BB2EED73Q50512896-ED0C7342-9C38-44D2-8D1F-EFFA35066DC5Q50708701-6097F252-3CDB-4558-BC08-B648BFA6EBE7Q50723955-1241C814-35BB-4BC4-A341-0E8A1604C1C5Q51585370-35FEC8FB-8A0C-4D91-A5A7-120DB5427D1AQ54398068-5B653DB6-B9DC-41D2-A1A2-7490DFA4A913Q60050522-C0C8433C-570F-4664-B661-1A72F9116B1FQ72314195-84E3CF2B-F2D8-4F98-B7CB-51E5C33335C8Q72580460-192635EF-872B-417B-82AE-CBF1B8F89CB4Q73142948-EE4B99B1-D980-4A5C-B4BA-AEDF3A5572E0Q79671063-DAE553AD-A2AF-45DC-B254-FB3B3D8053B3Q80044442-2894CB50-4E66-4290-A67E-8DC1767A6CF4Q80148508-63358135-FFB8-452F-B2C4-5EE07BC9A982Q83125271-3B8959FD-A1F9-4BAC-A019-52D9966C9EC2Q85026041-46BA632A-1DEA-4C73-ACB7-1EC417002006
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
研究者
@zh
name
Vincenzo Ostilio Palmieri
@ast
Vincenzo Ostilio Palmieri
@en
Vincenzo Ostilio Palmieri
@es
Vincenzo Ostilio Palmieri
@nl
type
label
Vincenzo Ostilio Palmieri
@ast
Vincenzo Ostilio Palmieri
@en
Vincenzo Ostilio Palmieri
@es
Vincenzo Ostilio Palmieri
@nl
prefLabel
Vincenzo Ostilio Palmieri
@ast
Vincenzo Ostilio Palmieri
@en
Vincenzo Ostilio Palmieri
@es
Vincenzo Ostilio Palmieri
@nl
P106
P1153
7102547623
P21
P31
P496
0000-0002-7649-6028